Paper37242528
Polyglactin 910 Meshes Coated with Sustained-Release Cannabigerol Varnish Inhibit Staphylococcus aureus Biofilm Formation and Macrophage Cytokine Secretion: An In Vitro Study.
Abudalu M and 7 others. Pharmaceuticals (Basel), 2023. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Polyglactin 910 Meshes Coated with Sustained-Release Cannabigerol Varnish Inhibit Staphylococcus aureus Biofilm Formation and Macrophage Cytokine Secretion: An In Vitro Study. Papers, record 37242528. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37242528
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Polyglactin 910 Meshes Coated with Sustained-Release Cannabigerol Varnish Inhibit Staphylococcus aureus Biofilm Formation and Macrophage Cytokine Secretion: An In Vitro Study.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 0 | STEP-GTP | PubMed |
Source PubMed
References68
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35064459 | Risks and Prevention of Surgical Site Infection After Hernia Mesh Repair and the Predictive Utility of ACS-NSQIP. | J Gastrointest Surg | 2022 | https://conductscience.org/library/papers/35064459 | PubMed |
| 2 | 28455712 | Macrophages' Role in Tissue Disease and Regeneration. | Results Probl Cell Differ | 2017 | https://conductscience.org/library/papers/28455712 | PubMed |
| 3 | 24744186 | Biofilm formation and persistence on abiotic surfaces in the context of food and medical environments. | Arch Microbiol | 2014 | https://conductscience.org/library/papers/24744186 | PubMed |
| 4 | 28362216 | Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action. | Virulence | 2018 | https://conductscience.org/library/papers/28362216 | PubMed |
| 5 | 20009757 | Low-molecular-weight polyethylene glycol improves survival in experimental sepsis. | Crit Care Med | 2010 | https://conductscience.org/library/papers/20009757 | PubMed |
| 6 | 15153930 | Role of biofilm in catheter-associated urinary tract infection. | Am J Infect Control | 2004 | https://conductscience.org/library/papers/15153930 | PubMed |
| 7 | 32017534 | Uncovering the Hidden Antibiotic Potential of Cannabis. | ACS Infect Dis | 2020 | https://conductscience.org/library/papers/32017534 | PubMed |
| 8 | 35019111 | COMPARATIVE ANALYSIS OF TISSULAR RESPONSE AFTER ABDOMINAL WALL REPAIR USING POLYPROPYLENE MESH AND BOVINE PERICARDIUM MESH. | Arq Bras Cir Dig | 2022 | https://conductscience.org/library/papers/35019111 | PubMed |
| 9 | 25769292 | Local sustained-release delivery systems of the antibiofilm agent thiazolidinedione-8 for prevention of catheter-associated urinary tract infections. | Int J Pharm | 2015 | https://conductscience.org/library/papers/25769292 | PubMed |
| 10 | 35572682 | Cannabigerol Effect on Streptococcus mutans Biofilms-A Computational Approach to Confocal Image Analysis. | Front Microbiol | 2022 | https://conductscience.org/library/papers/35572682 | PubMed |
| 11 | 34683353 | Anti-Biofilm Activity of Cannabigerol against Streptococcus mutans. | Microorganisms | 2021 | https://conductscience.org/library/papers/34683353 | PubMed |
| 12 | 31216688 | Sustained Release Technology and Its Application in Environmental Remediation: A Review. | Int J Environ Res Public Health | 2019 | https://conductscience.org/library/papers/31216688 | PubMed |
| 13 | 26779487 | Evidence for Replacement of an Infected Synthetic by a Biological Mesh in Abdominal Wall Hernia Repair. | Front Surg | 2015 | https://conductscience.org/library/papers/26779487 | PubMed |
| 14 | 29075100 | Biodegradable rifampicin-releasing coating of surgical meshes for the prevention of bacterial infections. | Drug Des Devel Ther | 2017 | https://conductscience.org/library/papers/29075100 | PubMed |
| 15 | 26556805 | Preclinical Bioassay of a Polypropylene Mesh for Hernia Repair Pretreated with Antibacterial Solutions of Chlorhexidine and Allicin: An In Vivo Study. | PLoS One | 2015 | https://conductscience.org/library/papers/26556805 | PubMed |
| 16 | 35887277 | The Origin and Biomedical Relevance of Cannabigerol. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35887277 | PubMed |
| 17 | 29042186 | Bacterial biofilm and associated infections. | J Chin Med Assoc | 2018 | https://conductscience.org/library/papers/29042186 | PubMed |
| 18 | 27454813 | Sustained-release drug delivery of antimicrobials in controlling of supragingival oral biofilms. | Expert Opin Drug Deliv | 2017 | https://conductscience.org/library/papers/27454813 | PubMed |
| 19 | 19582833 | Angiogenic and inflammatory host response to surgical meshes of different mesh architecture and polymer composition. | J Biomed Mater Res B Appl Biomater | 2009 | https://conductscience.org/library/papers/19582833 | PubMed |
| 20 | 36830745 | Therapeutic Potential of Phytocannabinoid Cannabigerol for Multiple Sclerosis: Modulation of Microglial Activation In Vitro and In Vivo. | Biomolecules | 2023 | https://conductscience.org/library/papers/36830745 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41011080 | Impact of Pancreatic Stump Wrapping with Mesh on Post-Operative Pancreatic Fistula in Patients Undergoing Distal/Left Pancreatectomy for Malignant or Benign Diseases: A Systematic Review and Meta-Analysis. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/41011080 | PubMed |
| 40284458 | The Incorporation of CBD into Biodegradable DL-Lactide/Glycolide Copolymers Creates a Persistent Antibacterial Environment: An In Vitro Study on Streptococcus mutans and Staphylococcus aureus. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40284458 | PubMed |
| 39956879 | Ion release, cytocompatibility and microbial inhibition of a novel varnish containing fluoride-doped bioactive glass ceramics: an in vitro study. | Clin Oral Investig | 2025 | https://conductscience.org/library/papers/39956879 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37242528
GET https://conductscience.org/api/papers/v1/37242528/references?page=2